Showing results (501-510 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2025
Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron EraHajime Yasuda, Jun Ando, Miki Ando
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2025
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive OverviewAmanda Caruso, Filomena Emanuela Laddaga, Alba Fiorentino, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple MyelomaMatthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2025
Maintenance Rituximab Following Rituximab Induction for Follicular Lymphoma: A Single-Center ExperienceLukas L Lauer, Craig A Portell
Clinical Lymphoma, Myeloma & Leukemia|October 19, 2025
The Unmet Psychological Needs of People Living With Multiple Myeloma and Smouldering Myeloma: A Review of Current Approaches and Future DirectionsNatalie Tuckey, Matthew Iasiello, Kathina Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 4, 2025
Causes of Death Among Waldenström Macroglobulinemia Patients: A Population-Based StudyDan Li, Jiongping Han, Jing Jin, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2020
Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different AgesJiansheng Zhong, Xiaoyang Yu, Xing Zhang
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2019
Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related MortalityKazuki Sakatoku, Yasunobu Takeoka, Akiko Miura, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2020
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With MyelomaEfstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 17, 2020
The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin LymphomaVedia Ozturk, Aysun Senturk Yikilmaz, Aydan Kilicarslan, et al.
Pageof 251